Genentech gets US hearing on Avastin, breast cancer – Reuters

by Blogburger on February 25, 2011


Daily Health Report
Genentech gets US hearing on Avastin, breast cancer
Reuters
WASHINGTON, Feb 24 (Reuters) – Genentech has won a second chance to convince US regulators that its Avastin drug is a safe and effective treatment for breast cancer. The drugmaker, part of Roche Holding AG (ROG.
FDA Grants Hearing on Withdrawal of Bevacizumab ApprovalInternal Medicine News Digital Network
Prescriptions: F.D.A. Grants Hearing on Avastin as Treatment for Breast CancerNew York Times (blog)
Genentech Gets FDA HearingXconomy
Wall Street Journal -Becker’s ASC Review -Bloomberg
all 235 news articles »

Health – Google News

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: